Renalytix Plc (LON:RENX – Get Free Report)’s share price traded down 4.6% on Tuesday . The stock traded as low as GBX 30 ($0.37) and last traded at GBX 31 ($0.39). 34,497 shares were traded during mid-day trading, a decline of 94% from the average session volume of 618,802 shares. The stock had previously closed at GBX 32.50 ($0.40).
Renalytix Price Performance
The firm has a market cap of £34.78 million, a price-to-earnings ratio of -80.56 and a beta of 1.92. The company has a current ratio of 0.59, a quick ratio of 2.42 and a debt-to-equity ratio of 173.95. The stock’s fifty day moving average price is GBX 32.84 and its 200-day moving average price is GBX 28.03.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Recommended Stories
- Five stocks we like better than Renalytix
- Consumer Discretionary Stocks Explained
- Comprehensive PepsiCo Stock Analysis
- What is the Euro STOXX 50 Index?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Find and Profitably Trade Stocks at 52-Week Lows
- Bear Market Funds to Watch This Year
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.